Corcept Therapeutics Incorporated financial statements, including revenue, expenses, profit, and loss

The total revenue of CORT for the last quarter is 182.55 M USD, and it's 11.45% higher compared to the previous quarter. The net income of Q3 24 is 46.69 M USD.